← Oncology Approval Tracker

FDA DECISION ·

Keytruda

pembrolizumab · Merck

Traditional approvalTraditional conversionGastric and gastroesophageal junction cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

With trastuzumab and fluoropyrimidine- plus platinum-containing chemotherapy as initial treatment for adults with locally advanced unresectable or metastatic HER2-positive gastric or GEJ adenocarcinoma and PD-L1 CPS of at least 1.

LAMPGEN ANALYSIS

Why it matters

KEYNOTE-811 supported traditional approval for the PD-L1-positive subgroup after an earlier accelerated approval.

What research teams should watch

Organize HER2 and PD-L1 testing together so first-line regimen decisions use both results before treatment starts.

PRIMARY RECORDS

Sources